Center-Authored Papers

Filters: Author is Rugo, Hope S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2010
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
2012
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG et al..  2012.  Antiemesis.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(4):456-85.
2014
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Kaufman PA, Bloom KJ, Burris H, Gralow JR, Mayer M, Pegram M, Rugo HS, Swain SM, Yardley DA, Chau M et al..  2014.  Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.. Cancer. Abstract
Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AKP et al..  2014.  Senior adult oncology, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(1):82-126. Abstract
Antineoplastic Combined Chemotherapy Protocols
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Benzamides
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Carboplatin
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Center-Authored Paper
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
Clinical Research Division
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG et al..  2012.  Antiemesis.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(4):456-85.
Kaufman PA, Bloom KJ, Burris H, Gralow JR, Mayer M, Pegram M, Rugo HS, Swain SM, Yardley DA, Chau M et al..  2014.  Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.. Cancer. Abstract
Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AKP et al..  2014.  Senior adult oncology, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(1):82-126. Abstract
Counseling
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
Deoxycytidine
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
DISEASE PROGRESSION
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Disease-Free Survival
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Fatigue
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
February 2014
Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AKP et al..  2014.  Senior adult oncology, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(1):82-126. Abstract
Female
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
Humans
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
July 2014
Kaufman PA, Bloom KJ, Burris H, Gralow JR, Mayer M, Pegram M, Rugo HS, Swain SM, Yardley DA, Chau M et al..  2014.  Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.. Cancer. Abstract
Kaplan-Meier Estimate
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract
May 2012
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG et al..  2012.  Antiemesis.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(4):456-85.
Middle Aged
O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P et al..  2014.  Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34):3840-7. Abstract